Patents by Inventor June Harland

June Harland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6641995
    Abstract: A method is disclosed for identifying a substance capable of disrupting an interaction between (i) a herpes simplex virus (HSV) ICP34.5 polypeptide or a homologue thereof, or a derivative thereof, and (ii) proliferating cell nuclear antigen (PCNA) or a homologue thereof, or a derivative thereof, which method comprises: (a) providing an HSV ICP34.5 polypeptide or a homologue thereof, or a derivative thereof, as a first component; (b) providing PCNA, or a homologue thereof, or a derivative thereof, as a second component; (c) contacting the two components with a substance to be tested under conditions that would permit the two components to interact in the absence of the said substance; and (d) determining whether the said substance disrupts the interaction between the first and second components.
    Type: Grant
    Filed: December 29, 2000
    Date of Patent: November 4, 2003
    Assignee: The University Court of the University of Glasgow
    Inventors: Susanne M. Brown, Alasdair R. Maclean, June Harland
  • Patent number: 6235467
    Abstract: The present invention relates to a method for identifying a substance capable of disrupting an interaction between (i) a herpes simplex virus (HSV) ICP34.5 polypeptide or a homologue thereof, or a derivative thereof, and (ii) proliferating cell nuclear antigen (PCNA) or a homologue thereof, or a derivative thereof. The method comprises: (a) providing an HSV ICP34.5 polypeptide or a homologue thereof, or a derivative thereof, as a first component; (b) providing PCNA, or a homologue thereof, or a derivative thereof, as a second component; (c) contacting the two components with a substance to be tested under conditions that would permit the two components to interact in the absence of the substance; and (d) determining whether the substance disrupts the interaction between the first and second components.
    Type: Grant
    Filed: November 29, 1999
    Date of Patent: May 22, 2001
    Assignees: Medical Research Council, The University Court of the University of Glasgow
    Inventors: Susanne M. Brown, Alasdair R. Maclean, June Harland
  • Publication number: 20010001058
    Abstract: A methods is disclosed for identifying a substance capable of disrupting an interaction between (i) a herpes simplex virus (HSV) ICP34.5 polypeptide or a homologue thereof, or a derivative thereof, and (ii) proliferating cell nuclear antigen (PCNA) or a homologue thereof, or a derivative thereof, which method comprises: (a) providing an HSV ICP34.5 polypeptide or a homologue thereof, or a derivative thereof, as a first component; (b) providing PCNA, or a homologue thereof, or a derivative thereof, as a second component; (c) contacting the two components with a substance to be tested under conditions that would permit the two components to interact in the absence of the said substance; and (d) determining whether the said substance disrupts the interaction between the first and second components.
    Type: Application
    Filed: December 29, 2000
    Publication date: May 10, 2001
    Applicant: MEDICAL RESEARCH COUNCIL AND THE UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW
    Inventors: Susanne M. Brown, Alasdair R. Maclean, June Harland